Pyrrolidinedithiocarbamate ammonium
Based on 154 publication(s) in Google Scholar
Pyrrolidinedithiocarbamate ammonium (Ammonium pyrrolidinedithiocarbamate) is a selective and blood-brain barrier (BBB) permeable NF-κB inhibitor.
For research use only. We do not sell to patients.
- Purity: 98.0%
- CAS No.: 5108-96-3
- Formula: C5H12N2S2
- Molecular Weight:164.29
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications Citing Use of MedChemExpress (MCE) Pyrrolidinedithiocarbamate ammonium
More- Signal Transduct Target Ther. 2023 Mar 15;8(1):107. [Abstract]
- Imeta. 2026 Jun 14.
- Mil Med Res. 2023 Nov 25;10(1):56. [Abstract]
- Nat Commun. 2025 May 27;16(1):4887. [Abstract]
- Nat Commun. 2024 Sep 12;15(1):7996. [Abstract]
- Nat Commun. 2024 Jan 10;15(1):449. [Abstract]
- Redox Biol. 2021 Oct;46:102098. [Abstract]
- Gut Microbes. 2024 Jan-Dec;16(1):2313769. [Abstract]
- J Nanobiotechnology. 2025 Jul 5;23(1):488. [Abstract]
- Microbiome. 2023 Jan 31;11(1):17. [Abstract]
- Theranostics. 2021 Jan 19;11(7):3392-3416. [Abstract]
- Acta Pharm Sin B. 2025 Mar;15(3):1535-1551. [Abstract]
- Acta Pharm Sin B. 2022 Sep;12(9):3618-3638. [Abstract]
- Cell Rep Med. 2025 Feb 18;6(2):101922. [Abstract]
- Cell Rep Med. 2024 Jun 18;5(6):101580. [Abstract]
- Sci Adv. 2025 Aug;11(31):eadu4270. [Abstract]
- Cell Death Dis. 2025 Apr 26;16(1):346. [Abstract]
- Cell Death Dis. 2021 Jan 11;12(1):67. [Abstract]
- Cell Death Dis. 2019 Feb 8;10(2):113. [Abstract]
- Pharmacol Res. 2018 Jul:133:218-235. [Abstract]
- Int J Biol Sci. 2025 Aug 11;21(12):5206-5222. [Abstract]
- Int J Biol Sci. 2019 Jan 24;15(3):688-700. [Abstract]
- J Exp Med. 2020 Jul 6;217(7):e20192083. [Abstract]
- J Neuroinflammation. 2021 Jun 28;18(1):146. [Abstract]
- Phytomedicine. 2025 Sep:145:157009. [Abstract]
- Phytomedicine. 2022 Sep:104:154290. [Abstract]
- EBioMedicine. 2024 Oct:108:105344. [Abstract]
- Acta Pharmacol Sin. 2025 Aug;46(8):2163-2179. [Abstract]
- Acta Pharmacol Sin. 2023 Aug;44(8):1712-1724. [Abstract]
- J Transl Med. 2025 Nov 13;23(1):1278. [Abstract]
- Diabetes. 2024 Sep 1;73(9):1513-1526. [Abstract]
- Dev Cell. 2025 Jun 23;60(12):1751-1767.e9. [Abstract]
- Oncogene. 2022 Mar;41(13):1866-1881. [Abstract]
- Int J Biol Macromol. 2026 Jun:369:152765. [Abstract]
- J Headache Pain. 2025 May 1;26(1):97. [Abstract]
- J Headache Pain. 2024 Jan 5;25(1):3. [Abstract]
- Int J Biol Macromol. 2022 Oct 21;S0141-8130(22)02401-1. [Abstract]
- JACC Basic Transl Sci. 2022 Aug 3;7(8):820-840. [Abstract]
- Mol Med. 2023 Aug 21;29(1):113. [Abstract]
- Mol Med. 2021 Dec 11;27(1):156. [Abstract]
- Phytother Res. 2023 Oct;37(10):4771-4790. [Abstract]
- Clin Transl Med. 2022 Jun;12(6):e850. [Abstract]
- Cell Rep. 2026 Jan 21;45(2):116899. [Abstract]
- Cell Rep. 2026 Jan 3;45(1):116683. [Abstract]
- Brain Behav Immun. 2025 Oct:129:801-817. [Abstract]
- Brain Behav Immun. 2020 Nov:90:108-137. [Abstract]
- Chin Med. 2026 Jan 4;21(1):1. [Abstract]
- Int J Oncol. 2020 Jan;56(1):101-112. [Abstract]
- J Ethnopharmacol. 2023 Sep 15:313:116533. [Abstract]
- Biomater Adv. 2026 Jun:183:214767. [Abstract]
- Life Sci. 2025 Nov 1:380:123926. [Abstract]
- Life Sci. 2025 Jul 15:373:123663. [Abstract]
- Ann Hepatol. 2024 Mar-Apr;29(2):101279. [Abstract]
- Liver Int. 2022 Dec;42(12):2724-2742. [Abstract]
- Food Biosci. 2021, 101268.
- Oncoimmunology. 2018 Aug 23;7(11):e1461303. [Abstract]
- Int J Pharm. 2022 Nov 25:628:122361. [Abstract]
- EMBO Rep. 2021 Jul 5;22(7):e51678. [Abstract]
- Pharmaceuticals (Basel). 2025 Jun 20;18(7):934. [Abstract]
- Int J Mol Sci. 2026 Jan;27(11):4811. [Abstract]
- Int Immunopharmacol. 2025 Nov 14:165:115451. [Abstract]
- Int Immunopharmacol. 2024 Sep 19;142(Pt B):113151. [Abstract]
- Int Immunopharmacol. 2023 Aug:121:110433. [Abstract]
- Int J Mol Sci. 2023 Jul 11;24(14):11331. [Abstract]
- Int J Mol Sci. 2021 Nov 11;22(22):12188. [Abstract]
- Int Immunopharmacol. 2021 Jul:96:107779. [Abstract]
- Int J Mol Sci. 2020 Dec 23;22(1):60. [Abstract]
- Int Immunopharmacol. 2020 Jan:78:106043. [Abstract]
- Int Immunopharmacol. 2019 May:70:28-36. [Abstract]
- Mol Neurobiol. 2022 Nov;59(11):6903-6917. [Abstract]
- Mol Neurobiol. 2021 Aug;58(8):3848-3862. [Abstract]
- J Periodontal Res. 2024 Feb;59(1):140-150. [Abstract]
- Inflammation. 2021 Aug;44(4):1581-1591. [Abstract]
- Inflammation. 2020 Jun;43(3):916-936. [Abstract]
- BMC Microbiol. 2019 Jul 29;19(1):170. [Abstract]
- Front Cell Dev Biol. 2021 Feb 11:9:570451. [Abstract]
- Chem Biol Interact. 2022 Sep 25:365:110068. [Abstract]
- Eye Vis (Lond). 2022 Sep 5;9(1):35. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2026 May 3;1872(6):168282. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2023 Oct;1869(7):166819. [Abstract]
- Mol Med Rep. 2020 Nov;22(5):4227-4235. [Abstract]
- Sci Rep. 2024 Nov 4;14(1):26583. [Abstract]
- Mediators Inflamm. 2020 Jul 24:2020:8298615. [Abstract]
- Cancers (Basel). 2023 Mar 6;15(5):1624. [Abstract]
- Neuropharmacology. 2025 Nov 15:279:110638. [Abstract]
- J Dairy Sci. 2025 Mar;108(3):2152-2168. [Abstract]
- Cell Signal. 2024 Dec:124:111427. [Abstract]
- J Dairy Sci. 2024 Nov;107(11):8852-8864. [Abstract]
- J Dairy Sci. 2023 Feb;106(2):1315-1329. [Abstract]
- Cell Signal. 2021 Nov:87:110137. [Abstract]
- Microorganisms. 2021 Sep 17;9(9):1983. [Abstract]
- J Inflamm Res. 2026 Mar 12:19:572609. [Abstract]
- J Inflamm Res. 2026 Jan 8;19:1-16.
- J Inflamm Res. 2021 Oct 5;14:5079-5094. [Abstract]
- J Inflamm Res. 2021 Mar 5:14:719-735. [Abstract]
- Neurochem Res. 2026 May 18;51(3):159. [Abstract]
- Gynecol Oncol. 2026 Feb:205:17-26. [Abstract]
- Metabolites. 2026 Jan 8;16(1):53. [Abstract]
- J Periodontol. 2025 Mar;96(3):255-267. [Abstract]
- Brain Res Bull. 2021 Dec:177:22-30. [Abstract]
- Aquaculture. 2025 Sep 15.
- Antiviral Res. 2023 Feb 20;105559. [Abstract]
- J Virol. 2025 Aug 19;99(8):e0065525. [Abstract]
- J Cell Physiol. 2019 Dec;234(12):23302-23314. [Abstract]
- J Cell Physiol. 2019 Aug;234(10):18731-18747. [Abstract]
- Microb Pathog. 2025 Jul:204:107559. [Abstract]
- Vet Res. 2024 Jul 29;55(1):93. [Abstract]
- Exp Biol Med. 2023 Feb;248(4):293-301. [Abstract]
- Brain Behav Immun Health. 2022 Oct 29:26:100546. [Abstract]
- Pathol Res Pract. 2025 Oct 17;276:156273.
- Mol Immunol. 2022 Dec:152:67-77. [Abstract]
- J Nat Prod. 2021 Apr 23;84(4):1022-1033. [Abstract]
- Parasit Vectors. 2020 Aug 31;13(1):435. [Abstract]
- Cytokine. 2023 Feb:162:156086. [Abstract]
- Cancer Med. 2026 Apr;15(4):e71822. [Abstract]
- Arch Biochem Biophys. 2020 Feb 15:680:108242. [Abstract]
- Vaccines. 2019 Dec 14;7(4):216. [Abstract]
- Mol Oral Microbiol. 2026 Aug;41(4):216-226. [Abstract]
- Andrology. 2023 Mar;11(3):575-590. [Abstract]
- J Alzheimers Dis. 2022;85(1):167-178. [Abstract]
- J Integr Neurosci. 2025 Jun 23;24(6):38100. [Abstract]
- PPAR Res. 2021 Aug 25:2021:6086265. [Abstract]
- Am J Cancer Res. 2023 Feb 15;13(2):419-435. [Abstract]
- FEBS Lett. 2021 Oct;595(19):2447-2462. [Abstract]
- Exp Eye Res. 2021 Apr:205:108507. [Abstract]
- PLoS One. 2026 Mar 6;21(3):e0344474. [Abstract]
- PLoS One. 2026 Jan 9;21(1):e0340382. [Abstract]
- Dig Dis Sci. 2025 Aug 5. [Abstract]
- Hum Cell. 2023 Nov;36(6):1928-1937. [Abstract]
- Vet Sci. 2024 May 8;11(5):204. [Abstract]
- Lasers Med Sci. 2023 Oct 18;38(1):240. [Abstract]
- Vet Parasitol. 2022 May;305:109710. [Abstract]
- Am J Transl Res. 2018 Dec 15;10(12):4247-4257. [Abstract]
- Mol Cell Toxicol. 2025 Dec 29.
- Andrologia. 2026 May 25;2026(1):5522224.
- bioRxiv. 2025 Aug 13:2025.08.11.669793. [Abstract]
- Res Sq. 2025 Mar 16.
- Sci Total Environ. 2024 Nov 1:949:175139. [Abstract]
- Sci Total Environ. 2024 Jul 10:933:173079. [Abstract]
- SSRN. 2024 Jan 9.
- Research Square Preprint. 2023 Dec 1.
- Heliyon. 2023 Nov 20;9(12):e22599. [Abstract]
- Research Square Preprint. 2023 Jul 25.
- Research Square Print. December 14th, 2022.
- Research Square Print. 2022 Aug.
- Research Square Preprint. July 21st, 2022.
- Research Square Print. 2022 Jun.
- Research Square Preprint. 2021 Jul.
- Evid Based Complement Alternat Med. 2021 Apr 1:2021:6662261. [Abstract]
- Oxid Med Cell Longev. 2021 Mar 29:2021:6678276. [Abstract]
- Research Square Preprint. 2021 Jan.
- Oncogene. 2020 Feb;39(7):1414-1428. [Abstract]
- Biomed Pharmacother. 2019 Dec:120:109527. [Abstract]
- Oxid Med Cell Longev. 2017:2017:3869561. [Abstract]
-
Cell Proliferation/Viability Assay
-
RT-PCR
-
RT-PCR
-
WB
-
RT-PCR
Biological Activity
|
NF-κB |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| ACHN | GI50 |
0.23 μM
Compound: PDTC
|
Cytotoxicity against human ACHN cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
Cytotoxicity against human ACHN cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
|
[PMID: 25953156] |
| BV-2 | IC50 |
10.8 μM
Compound: PDTC
|
Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay
Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay
|
[PMID: 28169537] |
| HCT-15 | GI50 |
0.13 μM
Compound: PDTC
|
Cytotoxicity against human HCT15 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
Cytotoxicity against human HCT15 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
|
[PMID: 25953156] |
| Jurkat | IC50 |
5.12 μM
Compound: Pyrrolidinedithiocarbamate
|
Antiinflammatory activity in PMA induced human Jurkat cells assessed as inhibition of IL-2 production by EIA assay
Antiinflammatory activity in PMA induced human Jurkat cells assessed as inhibition of IL-2 production by EIA assay
|
[PMID: 36496202] |
| MDA-MB-231 | GI50 |
0.16 μM
Compound: PDTC
|
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
|
[PMID: 25953156] |
| NCI-H23 | GI50 |
0.1 μM
Compound: PDTC
|
Cytotoxicity against human NCI-H23 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
Cytotoxicity against human NCI-H23 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
|
[PMID: 25953156] |
| NUGC-3 | GI50 |
0.14 μM
Compound: PDTC
|
Cytotoxicity against human NUGC3 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
Cytotoxicity against human NUGC3 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
|
[PMID: 25953156] |
| PC-3 | GI50 |
0.17 μM
Compound: PDTC
|
Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by sulforhodamine B assay
|
[PMID: 25953156] |
| RAW264.7 | IC50 |
<0.4 μg/mL
Compound: APDC
|
Cytotoxicity against mouse RAW264.7 cells after 2 days by MTT assay
Cytotoxicity against mouse RAW264.7 cells after 2 days by MTT assay
|
[PMID: 15165136] |
| RAW264.7 | IC50 |
21 μg/mL
Compound: APDC
|
Inhibition of iNOS production in LPS-activated mouse RAW264.7 cells after 20 hrs
Inhibition of iNOS production in LPS-activated mouse RAW264.7 cells after 20 hrs
|
[PMID: 15165136] |
| RAW264.7 | IC50 |
3 μM
Compound: PDTC
|
Inhibition of LPS-induced NF-kappaB (unknown origin) activation transfected in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS challenge measured after 4 hrs by luciferase reporter gene assay
Inhibition of LPS-induced NF-kappaB (unknown origin) activation transfected in mouse RAW264.7 cells preincubated for 2 hrs followed by LPS challenge measured after 4 hrs by luciferase reporter gene assay
|
[PMID: 24128115] |
| RAW264.7 | IC50 |
34.5 μM
Compound: PDTC
|
Inhibition of NF-kappaB (unknown origin) transcriptional activity in LPS-induced mouse RAW264.7 cells after 1 hr by secreted alkaline phosphatase assay
Inhibition of NF-kappaB (unknown origin) transcriptional activity in LPS-induced mouse RAW264.7 cells after 1 hr by secreted alkaline phosphatase assay
|
[PMID: 25953156] |
| RAW264.7 | IC50 |
37 μM
Compound: PDTC
|
Inhibition of NF-kappaB (unknown origin) expressed in mouse RAW264.7 cells pretreated for 1 hr followed by stimulation with LPS measured after 6 hrs by luciferase reporter gene assay
Inhibition of NF-kappaB (unknown origin) expressed in mouse RAW264.7 cells pretreated for 1 hr followed by stimulation with LPS measured after 6 hrs by luciferase reporter gene assay
|
[PMID: 26928174] |
| RAW264.7 | IC50 |
37.2 μM
Compound: PDTC
|
Inhibition of transcriptional activity of NF-kappaB (unknown origin) transfected in LPS-stimulated mouse RAW264.7 cells after 16 hrs by secretory alkaline phosphatase reporter gene assay
Inhibition of transcriptional activity of NF-kappaB (unknown origin) transfected in LPS-stimulated mouse RAW264.7 cells after 16 hrs by secretory alkaline phosphatase reporter gene assay
|
[PMID: 24792464] |
| RAW264.7 | IC50 |
37.2 μM
Compound: PDTC
|
Inhibition of LPS-induced NFkappaB (unknown origin) transcriptional activity expressed in mouse RAW264.7 cells incubated for 16 hrs by SEAP based reporter gene assay
Inhibition of LPS-induced NFkappaB (unknown origin) transcriptional activity expressed in mouse RAW264.7 cells incubated for 16 hrs by SEAP based reporter gene assay
|
[PMID: 27096046] |
| THP-1 | IC50 |
6.11 μM
Compound: Pyrrolidinedithiocarbamate
|
Antiinflammatory activity in LPS induced human THP-1 cells assessed as inhibition of TNF-alpha production by EIA assay
Antiinflammatory activity in LPS induced human THP-1 cells assessed as inhibition of TNF-alpha production by EIA assay
|
[PMID: 36496202] |
| U-937 | IC50 |
8.3 μg/mL
Compound: PDTC
|
Inhibition of etoposide-induced apoptosis in human U937 cells assessed as inhibition of caspase 3 induction after 7 hrs
Inhibition of etoposide-induced apoptosis in human U937 cells assessed as inhibition of caspase 3 induction after 7 hrs
|
[PMID: 11374970] |
| U-937 | IC50 |
8.3 μg/mL
Compound: PDTC
|
Inhibition of etoposide-induced caspase 3 induction in human U937 cells after 7 hrs
Inhibition of etoposide-induced caspase 3 induction in human U937 cells after 7 hrs
|
[PMID: 11908994] |
Pretreatment of cells with Pyrrolidinedithiocarbamate ammonium (Ammonium pyrrolidinedithiocarbamate; 3-1000 μM) dose-dependently attenuate IL-8 production[1].
Furthermore, pyrrolidinedithiocarbamate ammonium (100 μM) suppresses the accumulation of IL-8 mRNA[1].
Pyrrolidinedithiocarbamate ammonium inhibits the activation of NF-κB, because it suppresses both NF-κB DNA binding and NF-κB-dependent transcriptional activity. NF-κB inhibition with pyrrolidinedithiocarbamate ammonium decrease IL-8 production by intestinal epithelial cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 5108-96-3
-
Appearance Solid
-
Molecular Weight 164.29
-
Formula C5H12N2S2
-
Color White to off-white
-
SMILES
SC(N1CCCC1)=S.N
-
Synonyms
Ammonium pyrrolidinedithiocarbamate; PDTC ammonium; APDC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (154)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation. [Abstract]2023 Mar 15;8(1):107. PMID: 36918544 -
-
Mil Med Res
Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-κB pathways. [Abstract]2023 Nov 25;10(1):56. PMID: 38001521 -
Nat Commun
Clustering of NLRP3 induced by membrane or protein scaffolds promotes inflammasome assembly. [Abstract]2025 May 27;16(1):4887. PMID: 40425567 -
Nat Commun
Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions. [Abstract]2024 Sep 12;15(1):7996. PMID: 39266508 -
Nat Commun
Microglia govern the extinction of acute stress-induced anxiety-like behaviors in male mice. [Abstract]2024 Jan 10;15(1):449. PMID: 38200023 -
Redox Biol
Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy. [Abstract]2021 Oct;46:102098. PMID: 34418601
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Redox Biol. 2021 Oct;46:102098. [Abstract]
Several specific pharmacological inhibitors, including Pyrrolidine dithiocarbamate (PDTC, 100 μM), Wortmannin (Wort), Stattic, PD98059 and Bisindolylmaleimide I (Bis), are pre-administered to the cardiomyocytes in the HG + Pae group and then the expression of Opa1 is quantified.
-
Gut Microbes
2024 Jan-Dec;16(1):2313769. PMID: 38353638 -
J Nanobiotechnology
Macrophage-mimetic liposomes co-delivering ceria and Ac2-26 peptide for penumbra protection in ischemic stroke. [Abstract]2025 Jul 5;23(1):488. PMID: 40618146 -
Microbiome
Gut microbiota-derived metabolites mediate the neuroprotective effect of melatonin in cognitive impairment induced by sleep deprivation. [Abstract]2023 Jan 31;11(1):17. PMID: 36721179 -
Theranostics
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. [Abstract]2021 Jan 19;11(7):3392-3416. PMID: 33537094
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Theranostics. 2021 Jan 19;11(7):3392-3416. [Abstract]
Treatment with NF-κB (PDTC) inhibitor in both PC9 and H1975 cells treated with different concentrations of specific inhibitor for 72 h and Western blotting is performed.
-
Acta Pharm Sin B
2025 Mar;15(3):1535-1551. PMID: 40370558 -
Acta Pharm Sin B
Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1 α/NF- κ B feedback pathway to inhibit liver fibrosis. [Abstract]2022 Sep;12(9):3618-3638. PMID: 36176909
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2022 Sep;12(9):3618-3638. [Abstract]
SCT2 depletion-senescent LX2 cells are treated with rIL-1α protein and addressed in NF-κB inhibitor PDTC (100 μM), and the analysis of mRNAs of proinflammatory SASP IL1A, IL1B, IL6 and IL8 by qPCR.
-
Cell Rep Med
MFGE8 induces anti-PD-1 therapy resistance by promoting extracellular vesicle sorting of PD-L1. [Abstract]2025 Feb 18;6(2):101922. PMID: 39842432 -
Cell Rep Med
Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia. [Abstract]2024 Jun 18;5(6):101580. PMID: 38776913 -
Sci Adv
Neuronal Reg3β/macrophage TNF-α-mediated positive feedback signaling contributes to pain chronicity in a rat model of CRPS-I. [Abstract]2025 Aug;11(31):eadu4270. PMID: 40749060 -
Cell Death Dis
MMP1-induced NF-κB activation promotes epithelial-mesenchymal transition and sacituzumab govitecan resistance in hormone receptor-positive breast cancer. [Abstract]2025 Apr 26;16(1):346. PMID: 40287412 -
Cell Death Dis
The HIV protease inhibitor Saquinavir attenuates sepsis-induced acute lung injury and promotes M2 macrophage polarization via targeting matrix metalloproteinase-9. [Abstract]2021 Jan 11;12(1):67. PMID: 33431821 -
Cell Death Dis
Decidual RANKL/RANK interaction promotes the residence and polarization of TGF-β1-producing regulatory γδ T cells. [Abstract]2019 Feb 8;10(2):113. PMID: 30737372
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2019 Feb 8;10(2):113. [Abstract]
After 1-h pretreatment with or without Pyrrolidinedithiocarbamate ammonium (PDTC, 100 μM) and 2-day co-culture with RANKL+ DSCs or ctrl DSCs, the MFI level of Foxp3 and TGF-β1 in d γδT (n = 8) were analyzed by FCM.
-
Pharmacol Res
Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia. [Abstract]2018 Jul:133:218-235. PMID: 29391237 -
Int J Biol Sci
ANXA6 Overexpression Causes Abnormal Decidual Macrophage-Trophoblast Crosstalk in Recurrent Spontaneous Abortion. [Abstract]2025 Aug 11;21(12):5206-5222. PMID: 40959268 -
Int J Biol Sci
Andrographolide Enhances TRAIL-Induced Apoptosis via p53-Mediated Death Receptors Up-Regulation and Suppression of the NF-кB Pathway in Bladder Cancer Cells. [Abstract]2019 Jan 24;15(3):688-700. PMID: 30745855
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Int J Biol Sci. 2019 Jan 24;15(3):688-700. [Abstract]
T24 cells are treated with PDTC at various concentrations for 24-h, and cell viability and IC50 values are measured using MTS assays.
-
J Exp Med
2020 Jul 6;217(7):e20192083. PMID: 32324863 -
J Neuroinflammation
Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF-κB signaling axis in APP/PS1 mice. [Abstract]2021 Jun 28;18(1):146. PMID: 34183019 -
Phytomedicine
Jing An decoction alleviates neuroinflammation in Tourette syndrome by regulating butyrate-mediated microbiota-gut-brain axis. [Abstract]2025 Sep:145:157009. PMID: 40674913 -
Phytomedicine
The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway. [Abstract]2022 Sep:104:154290. PMID: 35793597 -
EBioMedicine
Polymeric immunoglobulin receptor promotes Th2 immune response in the liver by increasing cholangiocytes derived IL-33: a diagnostic and therapeutic biomarker of biliary atresia. [Abstract]2024 Oct:108:105344. PMID: 39288533 -
Acta Pharmacol Sin
Glabridin as a selective Kv2.1 inhibitor ameliorates DPN pathology by disrupting the Aβ/Kv2.1/JNK/NF-κB/NLRP3/p-Tau pathway. [Abstract]2025 Aug;46(8):2163-2179. PMID: 40113986 -
Acta Pharmacol Sin
Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-κB p65-activated SLC7A11 transcription. [Abstract]2023 Aug;44(8):1712-1724. PMID: 36829052
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Acta Pharmacol Sin. 2023 Aug;44(8):1712-1724. [Abstract]
Pyrrolidinedithiocarbamate ammonium (PDTC; 100 μM; 24 h) decreases viability of HepG2 and Huh7 cells on the basis of aspirin.
-
J Transl Med
Exploring the role of cellular plasticity in metabolic dysfunction-associated steatosis and related molecular mechanisms. [Abstract]2025 Nov 13;23(1):1278. PMID: 41233849 -
Diabetes
Regulatory Role of NF-κB on HDAC2 and Tau Hyperphosphorylation in Diabetic Encephalopathy and the Therapeutic Potential of Luteolin. [Abstract]2024 Sep 1;73(9):1513-1526. PMID: 38869375 -
Dev Cell
STAT3-controlled CHI3L1/SPP1 positive feedback loop demonstrates the spatial heterogeneity and immune characteristics of glioblastoma. [Abstract]2025 Jun 23;60(12):1751-1767.e9. PMID: 39933531 -
Oncogene
Mesenchymal stromal cells equipped by IFNα empower T cells with potent anti-tumor immunity. [Abstract]2022 Mar;41(13):1866-1881. PMID: 35145233
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Oncogene. 2022 Mar;41(13):1866-1881. [Abstract]
The Cxcl10 mRNA expression in B16F0 cells treated with IFNα (1 000 U/ml) for 12 hours, in presence of PDTC (10 μM) or BAY 11-7082 (5 μM).
-
Int J Biol Macromol
Aryl hydrocarbon receptor alleviates intestinal ischemia/reperfusion-induced epithelial barrier damage by inhibiting the 5-hydroxytryptamine-mediated complement C3 cascade. [Abstract]2026 Jun:369:152765. PMID: 42214532 -
J Headache Pain
Inhibition of S100A4 decreases neurotoxic astrocyte reactivity and attenuates neuropathic pain via the TLR4/NF-κB pathway in a rat model of spinal nerve ligation. [Abstract]2025 May 1;26(1):97. PMID: 40312684 -
J Headache Pain
Microglia TREM1-mediated neuroinflammation contributes to central sensitization via the NF-κB pathway in a chronic migraine model. [Abstract]2024 Jan 5;25(1):3. PMID: 38177990 -
Int J Biol Macromol
Cultivated Artemisia rupestris L. polysaccharide CARP2 as an adjuvant for influenza vaccines to prolong immune responses. [Abstract]2022 Oct 21;S0141-8130(22)02401-1. PMID: 36280174
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Int J Biol Macromol. 2022 Oct 21;S0141-8130(22)02401-1. [Abstract]
TLR4 and downstream pathways are subjected to relevant western blotting. After the treatment with TJ-M2010, TRAF-stop, and PDTC (5 μM) for 1 h, DCs are stimulated with 10 μg/mL CARP2 for 0, 45, and 90 min.
-
JACC Basic Transl Sci
Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease. [Abstract]2022 Aug 3;7(8):820-840. PMID: 36061341
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: JACC Basic Transl Sci. 2022 Aug 3;7(8):820-840. [Abstract]
To pharmacologically inhibit NFκB, mice are given Pyrrolidinedithiocarbamate ammonium (PDTC; 100 mg/kg).
-
Mol Med
AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE/NF-κB/Caveolin-1 pathway. [Abstract]2023 Aug 21;29(1):113. PMID: 37605109 -
Mol Med
Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way. [Abstract]2021 Dec 11;27(1):156. PMID: 34895136 -
Phytother Res
NPLC0393 from Gynostemma pentaphyllum ameliorates Alzheimer's disease-like pathology in mice by targeting protein phosphatase magnesium-dependent 1A phosphatase. [Abstract]2023 Oct;37(10):4771-4790. PMID: 37434441 -
Clin Transl Med
Uterus globulin associated protein 1 (UGRP1) binds podoplanin (PDPN) to promote a novel inflammation pathway during Streptococcus pneumoniae infection. [Abstract]2022 Jun;12(6):e850. PMID: 35652821
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Clin Transl Med. 2022 Jun;12(6):e850. [Abstract]
PEMs are treated with the NF-κB inhibitor PDTC (100 μM) for 1 h followed by BSA or UGRP1 (0.5 μg/mL) treatment and Pam3CSK4 stimulation for 6 h to measure Il6 mRNA by qRT‐PCR .
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Clin Transl Med. 2022 Jun;12(6):e850. [Abstract]
PEMs are treated with the NF-κB inhibitor PDTC (100 μM) for 1h followed by BSA or UGRP1 (0.5 μg/mL) treatment for 6 h, then stimulated by Pam3CSK4 for 0.5 h, p65 in the whole cell lysate and nucleus is analysed by immunoblot.
-
Cell Rep
A positive feedback loop between FGR and p65 sustains satellite glial cell activation and chronic neuropathic pain. [Abstract]2026 Jan 21;45(2):116899. PMID: 41575848 -
Cell Rep
Macrophage glycine transporter supports IL-1β production by modulating the AKT1/mTOR/NLRP3 pathway. [Abstract]2026 Jan 3;45(1):116683. PMID: 41485223 -
Brain Behav Immun
Targeting RelA/NLRP3/CCL3 axis mitigates microglia inflammatory response and promotes recovery after spinal cord injury. [Abstract]2025 Oct:129:801-817. PMID: 40691997 -
Brain Behav Immun
Protective effect of Indole-3-carbinol, an NF-κB inhibitor in experimental paradigm of Parkinson's disease: In silico and in vivo studies. [Abstract]2020 Nov:90:108-137. PMID: 32800927 -
Chin Med
Fuzheng Jiedu formula attenuates acute pneumonia by coordinated regulation of macrophage NLRP3 inflammasome and neutrophil NETs. [Abstract]2026 Jan 4;21(1):1. PMID: 41484909 -
Int J Oncol
S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation. [Abstract]2020 Jan;56(1):101-112. PMID: 31746424 -
J Ethnopharmacol
Systems pharmacology reveals the mechanism of Astragaloside IV in improving immune activity on cyclophosphamide-induced immunosuppressed mice. [Abstract]2023 Sep 15:313:116533. PMID: 37100262 -
Biomater Adv
VEGF-Loaded HANB/F127DA photosensitive hydrogel in combination with exercise training: For improving post-myocardial infarction myocardial remodeling. [Abstract]2026 Jun:183:214767. PMID: 41702199 -
Life Sci
Exploring the hepatoprotective effects of perillyl alcohol in the experimental models of acute liver injury. [Abstract]2025 Nov 1:380:123926. PMID: 40850494 -
Life Sci
Targeted inhibition of JMJD2C/MALAT1 axis compensates for the deficiency of metformin in reversing ovarian cancer platinum resistance. [Abstract]2025 Jul 15:373:123663. PMID: 40280301 -
Ann Hepatol
Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells. [Abstract]2024 Mar-Apr;29(2):101279. PMID: 38123132 -
Liver Int
Human poliovirus receptor contributes to biliary atresia pathogenesis by exacerbating natural-killer-cell-mediated bile duct injury. [Abstract]2022 Dec;42(12):2724-2742. PMID: 36251580 -
-
Oncoimmunology
Th17 cell-derived IL-17A promoted tumor progression via STAT3/NF-κB/Notch1 signaling in non-small cell lung cancer. [Abstract]2018 Aug 23;7(11):e1461303. PMID: 30377557
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Oncoimmunology. 2018 Aug 23;7(11):e1461303. [Abstract]
The expression of Oct4 in A549 and H460 cells treated with or without rhIL-17A and these molecular inhibitors (NF-kB inhibitor: PDAC, Notch1 inhibitor: LY411575) are assessed by western blotting.
-
Int J Pharm
Norcantharidin liposome emulsion hybrid delivery system enhances PD-1/PD-L1 immunotherapy by agonizing the non-canonical NF-κB pathway. [Abstract]2022 Nov 25:628:122361. PMID: 36332828 -
EMBO Rep
Sensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection. [Abstract]2021 Jul 5;22(7):e51678. PMID: 33987949
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: EMBO Rep. 2021 Jul 5;22(7):e51678. [Abstract]
qPCR analysis of Mmps including Mmp9, Mmp10, and Mmp12 from THP‐1 cells stimulated with AG (1 μg/mL) for 24 h in the absence or presence of PDTC at the concentration of 10 μM.
-
Pharmaceuticals (Basel)
Research on Sinomenine Inhibiting the cGAS-STING Signaling Pathway to Alleviate Renal Inflammatory Injury in db/db Mice. [Abstract]2025 Jun 20;18(7):934. PMID: 40732224 -
Int J Mol Sci
Aspirin Eugenol Ester Ameliorates Fatty Liver Hemorrhagic Syndrome in Laying Hens by Reducing Oxidative Stress and Inflammation. [Abstract]2026 Jan;27(11):4811. PMID: 42278341 -
Int Immunopharmacol
Sidt2 ameliorates TNF-α-induced apoptosis and inflammation by promoting autophagic flux via p65 signaling. [Abstract]2025 Nov 14:165:115451. PMID: 40885088 -
Int Immunopharmacol
The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK/NF-kB signaling pathways in aging mice. [Abstract]2024 Sep 19;142(Pt B):113151. PMID: 39303538 -
Int Immunopharmacol
ROR1/STAT3 positive feedback loop facilitates cartilage degeneration in Osteoarthritis through activation of NF-κB signaling pathway. [Abstract]2023 Aug:121:110433. PMID: 37343369 -
Int J Mol Sci
Low Glucose plus β-Hydroxybutyrate Induces an Enhanced Inflammatory Response in Yak Alveolar Macrophages via Activating the GPR109A/NF-κB Signaling Pathway. [Abstract]2023 Jul 11;24(14):11331. PMID: 37511091 -
Int J Mol Sci
Cordyceps militaris Immunomodulatory Protein Promotes the Phagocytic Ability of Macrophages through the TLR4-NF-κB Pathway. [Abstract]2021 Nov 11;22(22):12188. PMID: 34830071 -
Int Immunopharmacol
Melatonin-mediated MT2 attenuates colitis induced by dextran sodium sulfate via PI3K/AKT/Nrf2/SIRT1/RORα/NF-κB signaling pathways. [Abstract]2021 Jul:96:107779. PMID: 34162146 -
Int J Mol Sci
Identifying the p65-Dependent Effect of Sulforaphene on Esophageal Squamous Cell Carcinoma Progression via Bioinformatics Analysis. [Abstract]2020 Dec 23;22(1):60. PMID: 33374641 -
Int Immunopharmacol
Protectin DX attenuates IL-1β-induced inflammation via the AMPK/NF-κB pathway in chondrocytes and ameliorates osteoarthritis progression in a rat model. [Abstract]2020 Jan:78:106043. PMID: 31837574 -
Int Immunopharmacol
Polydatin alleviates traumatic spinal cord injury by reducing microglial inflammation via regulation of iNOS and NLRP3 inflammasome pathway. [Abstract]2019 May:70:28-36. PMID: 30785088 -
Mol Neurobiol
Hydrogen Sulfide Attenuates High-Fat Diet-Induced Obesity: Involvement of mTOR/IKK/NF-κB Signaling Pathway. [Abstract]2022 Nov;59(11):6903-6917. PMID: 36053437 -
Mol Neurobiol
The mTOR/NF-κB Pathway Mediates Neuroinflammation and Synaptic Plasticity in Diabetic Encephalopathy. [Abstract]2021 Aug;58(8):3848-3862. PMID: 33860440 -
J Periodontal Res
2024 Feb;59(1):140-150. PMID: 37885312 -
Inflammation
MiR-23a Is Involved in Myocardial Ischemia/Reperfusion Injury by Directly Targeting CX43 and Regulating Mitophagy. [Abstract]2021 Aug;44(4):1581-1591. PMID: 33651309 -
Inflammation
2020 Jun;43(3):916-936. PMID: 31981062 -
BMC Microbiol
Lactobacillus plantarum C88 protects against aflatoxin B1-induced liver injury in mice via inhibition of NF-κB-mediated inflammatory responses and excessive apoptosis. [Abstract]2019 Jul 29;19(1):170. PMID: 31357935 -
Front Cell Dev Biol
MiR-132-3p Modulates MEKK3-Dependent NF-κB and p38/JNK Signaling Pathways to Alleviate Spinal Cord Ischemia-Reperfusion Injury by Hindering M1 Polarization of Macrophages. [Abstract]2021 Feb 11:9:570451. PMID: 33644040 -
Chem Biol Interact
Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways. [Abstract]2022 Sep 25:365:110068. PMID: 35917943 -
Eye Vis (Lond)
TRIM46 aggravated high glucose-induced hyper permeability and inflammatory response in human retinal capillary endothelial cells by promoting IκBα ubiquitination. [Abstract]2022 Sep 5;9(1):35. PMID: 36064447 -
Biochim Biophys Acta Mol Basis Dis
ZNF750 loss defines an ESCC subtype with constitutive NF-κB activation and vulnerability to bortezomib. [Abstract]2026 May 3;1872(6):168282. PMID: 42086128 -
Biochim Biophys Acta Mol Basis Dis
Senkyunolide I ameliorates thoracic aortic aneurysm and dissection in mice via inhibiting the oxidative stress and apoptosis of endothelial cells. [Abstract]2023 Oct;1869(7):166819. PMID: 37499930 -
Mol Med Rep
Berberine protects against diabetic retinopathy by inhibiting cell apoptosis via deactivation of the NF‑κB signaling pathway. [Abstract]2020 Nov;22(5):4227-4235. PMID: 33000205 -
Sci Rep
Phloretin attenuates inflammation induced by subarachnoid hemorrhage through regulation of the TLR2/MyD88/NF-kB pathway. [Abstract]2024 Nov 4;14(1):26583. PMID: 39496685 -
Mediators Inflamm
2020 Jul 24:2020:8298615. PMID: 32774151 -
Cancers (Basel)
PKCθ Regulates Pituitary Adenoma Bone Invasion by Activating Osteoclast in NF-κB/IL-1β-Dependent Manner. [Abstract]2023 Mar 6;15(5):1624. PMID: 36900414 -
Neuropharmacology
TIM3 attenuates morphine antinociceptive tolerance and microglial neuroinflammation by suppressing the TRAF6/NF-κB pathway in male mice. [Abstract]2025 Nov 15:279:110638. PMID: 40840715 -
J Dairy Sci
Immunomodulatory activity and molecular mechanisms of action of peptides derived from casein hydrolysate by alcalase and flavourzyme based on virtual screening. [Abstract]2025 Mar;108(3):2152-2168. PMID: 39603497 -
Cell Signal
2024 Dec:124:111427. PMID: 39304099 -
J Dairy Sci
Novel casein-derived immunomodulatory peptide PFPEVFG: Activity assessment, molecular docking, activity site and mechanism of action. [Abstract]2024 Nov;107(11):8852-8864. PMID: 39033908 -
J Dairy Sci
Sirtuin 3 relieves inflammatory responses elicited by lipopolysaccharide via the PGC1α-NFκB pathway in bovine mammary epithelial cells. [Abstract]2023 Feb;106(2):1315-1329. PMID: 36494223 -
Cell Signal
Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation. [Abstract]2021 Nov:87:110137. PMID: 34469786 -
Microorganisms
Lactobacillus johnsonii L531 Alleviates the Damage Caused by Salmonella Typhimurium via Inhibiting TLR4, NF-κB, and NLRP3 Inflammasome Signaling Pathways. [Abstract]2021 Sep 17;9(9):1983. PMID: 34576878 -
J Inflamm Res
Celastrol Mitigates Acute Pancreatitis Associated Inflammation by Modulating the IL-34/CSF-1R Axis and Suppressing NF-κB/ERK Signaling. [Abstract]2026 Mar 12:19:572609. PMID: 41847424 -
-
J Inflamm Res
The β3/5 Integrin-MMP9 Axis Regulates Pulmonary Inflammatory Response and Endothelial Leakage in Acute Lung Injury. [Abstract]2021 Oct 5;14:5079-5094. PMID: 34675589 -
J Inflamm Res
KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease. [Abstract]2021 Mar 5:14:719-735. PMID: 33727847 -
Neurochem Res
Electroacupuncture Promotes Synaptic Recovery After Cerebral Ischemia-Reperfusion by Activating SIRT1 to Inhibit the NF-κB Pathway and Regulate Astrocyte Phenotypic Transformation. [Abstract]2026 May 18;51(3):159. PMID: 42149357 -
Gynecol Oncol
Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer. [Abstract]2026 Feb:205:17-26. PMID: 41500072 -
Metabolites
2026 Jan 8;16(1):53. PMID: 41590661 -
J Periodontol
Cystathionine γ-lyase contributes to exacerbation of periodontal destruction in experimental periodontitis under hyperglycemia. [Abstract]2025 Mar;96(3):255-267. PMID: 38937859 -
Brain Res Bull
Berberine exerts neuroprotective activities against cerebral ischemia/reperfusion injury through up-regulating PPAR-γ to suppress NF-κB-mediated pyroptosis. [Abstract]2021 Dec:177:22-30. PMID: 34517069 -
-
Antiviral Res
Human adenovirus type 7 virus-like particle vaccine induces Dendritic cell maturation through the TLR4/NF-κB pathway and is highly immunogenic. [Abstract]2023 Feb 20;105559. PMID: 36813181 -
J Virol
The mRNA and protein of IL-8 oppositely regulate PRRSV replication via nucleoprotein and 14-3-3γ. [Abstract]2025 Aug 19;99(8):e0065525. PMID: 40704900 -
J Cell Physiol
LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway. [Abstract]2019 Dec;234(12):23302-23314. PMID: 31140621 -
J Cell Physiol
C1q/TNF-related protein-9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction. [Abstract]2019 Aug;234(10):18731-18747. PMID: 30953351 -
Microb Pathog
Actinobacillus pleuropneumoniae infection activates IL-1β expression in porcine alveolar macrophages via β-amyloid production. [Abstract]2025 Jul:204:107559. PMID: 40220800 -
Vet Res
HbpA from Glaesserella parasuis induces an inflammatory response in 3D4/21 cells by activating the MAPK and NF-κB signalling pathways and protects mice against G. parasuis when used as an immunogen. [Abstract]2024 Jul 29;55(1):93. PMID: 39075605 -
Exp Biol Med
2023 Feb;248(4):293-301. PMID: 36691330 -
Brain Behav Immun Health
Miltefosine as a PPM1A activator improves AD-like pathology in mice by alleviating tauopathy via microglia/neurons crosstalk. [Abstract]2022 Oct 29:26:100546. PMID: 36388134 -
-
Mol Immunol
The transcription factor KLF14 attenuates LPS-induced acute lung injury by ameliorating apoptosis of alveolar epithelial cells in mice. [Abstract]2022 Dec:152:67-77. PMID: 36279660 -
J Nat Prod
Discovering the Mechanisms of Wikstroelide E as a Potential HIV-Latency-Reversing Agent by Transcriptome Profiling. [Abstract]2021 Apr 23;84(4):1022-1033. PMID: 33721994 -
Parasit Vectors
Cryptosporidium parvum upregulates miR-942-5p expression in HCT-8 cells via TLR2/TLR4-NF-κB signaling. [Abstract]2020 Aug 31;13(1):435. PMID: 32867835 -
Cytokine
Knockdown of miR-150-5p reduces hypoxia-induced autophagy and epithelial-mesenchymal transition of endometriotic cells via regulating the PDCD4/NF-κB signaling pathway. [Abstract]2023 Feb:162:156086. PMID: 36427469 -
Cancer Med
2026 Apr;15(4):e71822. PMID: 41987392 -
Arch Biochem Biophys
2020 Feb 15:680:108242. PMID: 31899146 -
Vaccines
Polyamine Transport Protein PotD Protects Mice against Haemophilus parasuis and Elevates the Secretion of Pro-Inflammatory Cytokines of Macrophage via JNK-MAPK and NF-κB Signal Pathways through TLR4. [Abstract]2019 Dec 14;7(4):216. PMID: 31847381 -
Mol Oral Microbiol
Ginsenoside Compound K Plays an Anti-Inflammatory Role in Gingival Epithelial Cells Stimulated With Porphyromonas gingivalis by Regulating Pyruvate Kinase M2. [Abstract]2026 Aug;41(4):216-226. PMID: 41923291 -
Andrology
TNFα stimulates the proliferation of immature Sertoli cells by attenuating UPS-degradation of cyclin D1 and leads to the delay of BTB maturation in pubertal rats. [Abstract]2023 Mar;11(3):575-590. PMID: 36354278 -
J Alzheimers Dis
Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-β142-Induced Synaptotoxicity by Regulating Nerve Growth Factor. [Abstract]2022;85(1):167-178. PMID: 34776441 -
J Integr Neurosci
Harmine-mediated Reduction of Bone Cancer Pain in Rats Correlates With Suppressed DYRK1A/NF-κB Signaling Axis. [Abstract]2025 Jun 23;24(6):38100. PMID: 40613372 -
PPAR Res
Rosiglitazone Alleviates Mechanical Allodynia of Rats with Bone Cancer Pain through the Activation of PPAR- γ to Inhibit the NF- κ B/NLRP3 Inflammatory Axis in Spinal Cord Neurons. [Abstract]2021 Aug 25:2021:6086265. PMID: 34484316 -
Am J Cancer Res
Tumor-derived Immunoglobulin-like transcript 4 facilitates angiogenesis of colorectal cancer. [Abstract]2023 Feb 15;13(2):419-435. PMID: 36895964 -
FEBS Lett
2021 Oct;595(19):2447-2462. PMID: 34387860 -
Exp Eye Res
Prostaglandin E2 promotes pathological retinal neovascularisation via EP4R-EGFR-Gab1-AKT signaling pathway. [Abstract]2021 Apr:205:108507. PMID: 33609510 -
PLoS One
TLR9/MyD88/NF-κB signaling mediates mental stress-induced exacerbation of psoriasis through immune dysregulation in a mouse model. [Abstract]2026 Mar 6;21(3):e0344474. PMID: 41790734 -
PLoS One
Inhibition of TREM1 attenuates myocardial ischemia-reperfusion injury-induced cardiomyocyte pyroptosis by suppressing the activation of the NF-κB signaling pathway. [Abstract]2026 Jan 9;21(1):e0340382. PMID: 41511954 -
Dig Dis Sci
Role of AQP1 in the Ameliorating Effect of Electroacupuncture in a Rodent Model of Visceral Hypersensitivity. [Abstract]2025 Aug 5. PMID: 40762756 -
Hum Cell
Cofilin-1 induces acute kidney injury via the promotion of endoplasmic reticulum stress-mediated ferroptosis. [Abstract]2023 Nov;36(6):1928-1937. PMID: 37548903 -
Vet Sci
Host miR-146a-3p Facilitates Replication of Infectious Hematopoietic Necrosis Virus by Targeting WNT3a and CCND1. [Abstract]2024 May 8;11(5):204. PMID: 38787176 -
Lasers Med Sci
Low-energy LED red light inhibits the NF-κB pathway and promotes hPDLSCs proliferation and osteogenesis in a TNF-α environment in vitro. [Abstract]2023 Oct 18;38(1):240. PMID: 37851127 -
Vet Parasitol
Cryptosporidium parvum downregulates miR-181d in HCT-8 cells via the p50-dependent TLRs/NF-κB pathway. [Abstract]2022 May;305:109710. PMID: 35462275 -
Am J Transl Res
H2S promotes proliferation of endometrial stromal cells via activating the NF-κB pathway in endometriosis. [Abstract]2018 Dec 15;10(12):4247-4257. PMID: 30662667 -
-
-
bioRxiv
2025 Aug 13:2025.08.11.669793. PMID: 40832193 -
-
Sci Total Environ
PFOS impairs cardiac function and energy metabolism under high-fat diet: Insights into role of circulating macrophage emphasized by exposure distribution. [Abstract]2024 Nov 1:949:175139. PMID: 39084357 -
Sci Total Environ
Bacillus cereus CwpFM induces colonic tissue damage and inflammatory responses through oxidative stress and the NLRP3/NF-κB pathway. [Abstract]2024 Jul 10:933:173079. PMID: 38735331 -
-
-
Heliyon
Inhibition of Pard3 promotes breast cancer metastasis via the USP28 mediated deubiquitination of Snail1. [Abstract]2023 Nov 20;9(12):e22599. PMID: 38076191 -
-
-
-
-
-
-
Evid Based Complement Alternat Med
Dahuang Zhechong Pills Suppress Silicosis Fibrosis Progression via p38 MAPK/TGF- β 1/Smad Pathway In Vitro. [Abstract]2021 Apr 1:2021:6662261. PMID: 33868442 -
Oxid Med Cell Longev
Photobiomodulation Therapy Ameliorates Glutamatergic Dysfunction in Mice with Chronic Unpredictable Mild Stress-Induced Depression. [Abstract]2021 Mar 29:2021:6678276. PMID: 33859781 -
-
Oncogene
The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis. [Abstract]2020 Feb;39(7):1414-1428. PMID: 31659258 -
Biomed Pharmacother
AGEs impair Kv channel-mediated vasodilation of coronary arteries by activating the NF-κB signaling pathway in ZDF rats. [Abstract]2019 Dec:120:109527. PMID: 31629953
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2019 Dec:120:109527. [Abstract]
Treatment with aminoguanidine hydrochloride (AG, 100 mg/kg/d, dissolved in drinking water for 10 weeks), ALA , or PDTC (150 mg/kg/d, dissolved in drinking water for 10 weeks) significantly reduced the RAGE and 3‑NT levels in ZDF rats.
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2019 Dec:120:109527. [Abstract]
The protein expression of the NADPH oxidase subunits NOX2 and p22phox was significantly increased in the ZDF rats, while treatment with aminoguanidine hydrochloride (AG, 100 mg/kg/d, dissolved in drinking water for 10 weeks) or PDTC (150 mg/kg/d, dissolved in drinking water for 10 weeks) specifically reduced the NOX2 and p22phox levels in the ZDF rats.
-
Oxid Med Cell Longev
Expression and Role of the Calcium-Sensing Receptor in Rat Peripheral Blood Polymorphonuclear Neutrophils. [Abstract]2017:2017:3869561. PMID: 29081886
Pyrrolidinedithiocarbamate ammonium purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2017:2017:3869561. [Abstract]
N-formyl-Met-Leu-Phe (fMLP; 10 nM) are used to stimulate the cells for 2 min, and the polymorphonuclear neutrophils (PMNs) without fMLP serve as the control. NPS-2143 (100 nM), AMG 073 (100 nM), and PDTC (100 nM) are added and incubated. Protein expression results are representative of three experiments.
Solvent & Solubility
DMSO : 100 mg/mL (608.68 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 50 mg/mL (304.34 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 5 mg/mL (30.43 mM); Clear solution
This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 5 mg/mL (30.43 mM); Clear solution
This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 24 mg/mL (146.08 mM); Clear solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
Protocol
The human colon cancer cell line HT-29 is obtained and cells are grown in modified McCoy’s 5A medium supplemented with 10% fetal bovine serum. To study the effect of pyrrolidinedithiocarbamate ammonium on IL-8 production, HT-29 cells in 96-well plates are induced with 20 ng/mL of IL-1β for 18 h. Various concentrations (3-1000 μM) of pyrrolidinedithiocarbamate or its vehicle (culture medium) are added to the cells 30 min prior to IL-1β stimulation. The concentration of IL-8 in the supernatant is determined using solid-phase enzyme-linked immunosorbent assay[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Administration: [2]Pyrrolidinedithiocarbamate is administered intraperitoneally to mice at dose levels of 100 and 50 mg/kg. Mice are divided into a DSS-untreated group (normal group), DSS-treated control group, DSS+pyrrolidinedithiocarbamate-treated groupI (low-dose group), and DSS+pyrrolidinedithiocarbamate-treated groupII (high-dose group). In each group, the disease activity index score (DAI score), intestinal length, histological score, and the levels of activated NF-κB and inflammatory cytokines (IL-1β and TNF-α) in tissue are measured[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (281 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Németh ZH, et al. Pyrrolidinedithiocarbamate inhibits NF-kappaB activation and IL-8 production in intestinal epithelial cells. Immunol Lett. 2003 Jan 2;85(1):41-6. [Content Brief]
[2]. Qin JD, et al. Effect of ammonium pyrrolidine dithiocarbamate (PDTC) on NF-κB activation and CYP2E1 content of rats with immunological liver injury. Pharm Biol. 2014 Nov;52(11):1460-1466. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 6.0868 mL | 30.4340 mL | 60.8680 mL | 152.1699 mL |
| 5 mM | 1.2174 mL | 6.0868 mL | 12.1736 mL | 30.4340 mL | |
| 10 mM | 0.6087 mL | 3.0434 mL | 6.0868 mL | 15.2170 mL | |
| 15 mM | 0.4058 mL | 2.0289 mL | 4.0579 mL | 10.1447 mL | |
| 20 mM | 0.3043 mL | 1.5217 mL | 3.0434 mL | 7.6085 mL | |
| 25 mM | 0.2435 mL | 1.2174 mL | 2.4347 mL | 6.0868 mL | |
| 30 mM | 0.2029 mL | 1.0145 mL | 2.0289 mL | 5.0723 mL | |
| 40 mM | 0.1522 mL | 0.7608 mL | 1.5217 mL | 3.8042 mL | |
| 50 mM | 0.1217 mL | 0.6087 mL | 1.2174 mL | 3.0434 mL | |
| 60 mM | 0.1014 mL | 0.5072 mL | 1.0145 mL | 2.5362 mL | |
| 80 mM | 0.0761 mL | 0.3804 mL | 0.7608 mL | 1.9021 mL | |
| 100 mM | 0.0609 mL | 0.3043 mL | 0.6087 mL | 1.5217 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.